ArticleBMC neurology2025

Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3.

Chang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.